61 related articles for article (PubMed ID: 21212401)
1. Mast cell activation in vivo impairs the macrophage reverse cholesterol transport pathway in the mouse.
Lee-Rueckert M; Silvennoinen R; Rotllan N; Judström I; Blanco-Vaca F; Metso J; Jauhiainen M; Kovanen PT; Escola-Gil JC
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):520-7. PubMed ID: 21212401
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo.
Zhang Y; Zanotti I; Reilly MP; Glick JM; Rothblat GH; Rader DJ
Circulation; 2003 Aug; 108(6):661-3. PubMed ID: 12900335
[TBL] [Abstract][Full Text] [Related]
3. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
[TBL] [Abstract][Full Text] [Related]
4. Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma.
Lee M; von Eckardstein A; Lindstedt L; Assmann G; Kovanen PT
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1066-74. PubMed ID: 10195937
[TBL] [Abstract][Full Text] [Related]
5. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.
Lindstedt L; Lee M; Castro GR; Fruchart JC; Kovanen PT
J Clin Invest; 1996 May; 97(10):2174-82. PubMed ID: 8636396
[TBL] [Abstract][Full Text] [Related]
6. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
[TBL] [Abstract][Full Text] [Related]
7. Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4.
Hendrix S; Kramer P; Pehl D; Warnke K; Boato F; Nelissen S; Lemmens E; Pejler G; Metz M; Siebenhaar F; Maurer M
FASEB J; 2013 Mar; 27(3):920-9. PubMed ID: 23193170
[TBL] [Abstract][Full Text] [Related]
8. Mast cell-dependent proteolytic modification of HDL particles during anaphylactic shock in the mouse reduces their ability to induce cholesterol efflux from macrophage foam cells ex vivo.
Judström I; Jukkola H; Metso J; Jauhiainen M; Kovanen PT; Lee-Rueckert M
Atherosclerosis; 2010 Jan; 208(1):148-54. PubMed ID: 19679305
[TBL] [Abstract][Full Text] [Related]
9. The mast cell--a potential link between inflammation and cellular cholesterol deposition in atherogenesis.
Kovanen PT
Eur Heart J; 1993 Dec; 14 Suppl K():105-17. PubMed ID: 8131778
[TBL] [Abstract][Full Text] [Related]
10. Chymase-containing mast cells in human arterial intima: implications for atherosclerotic disease.
Kovanen PT
Heart Vessels; 1997; Suppl 12():125-7. PubMed ID: 9476562
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of human apolipoprotein A-II in transgenic mice does not impair macrophage-specific reverse cholesterol transport in vivo.
Rotllan N; Ribas V; Calpe-Berdiel L; Martín-Campos JM; Blanco-Vaca F; Escolà-Gil JC
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):e128-32. PubMed ID: 15994442
[TBL] [Abstract][Full Text] [Related]
12. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport.
Tanigawa H; Billheimer JT; Tohyama J; Zhang Y; Rothblat G; Rader DJ
Circulation; 2007 Sep; 116(11):1267-73. PubMed ID: 17709636
[TBL] [Abstract][Full Text] [Related]
13. Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.
Garner B; Mellor HR; Butters TD; Dwek RA; Platt FM
Biochem Biophys Res Commun; 2002 Feb; 290(5):1361-7. PubMed ID: 11820771
[TBL] [Abstract][Full Text] [Related]
14. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages.
Li Q; Tsujita M; Yokoyama S
Biochemistry; 1997 Oct; 36(40):12045-52. PubMed ID: 9315842
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of mast cell degranulation by compound 48/80 on peritoneal inflammation in Swiss and CBA mice.
Stankiewicz E; Wypasek E; Plytycz B
Pol J Pharmacol; 2001; 53(2):149-55. PubMed ID: 11787955
[TBL] [Abstract][Full Text] [Related]
16. Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol.
Lee M; Sommerhoff CP; von Eckardstein A; Zettl F; Fritz H; Kovanen PT
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):2086-91. PubMed ID: 12482839
[TBL] [Abstract][Full Text] [Related]
17. Mast cell distribution, activation, and phenotype in xanthoma.
Matsumoto M; Kunimitsu S; Wada K; Ikeda M; Keyama A; Kodama H
J Am Acad Dermatol; 2007 Jun; 56(6):1006-12. PubMed ID: 17504717
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cells.
Nguyen SD; Öörni K; Lee-Rueckert M; Pihlajamaa T; Metso J; Jauhiainen M; Kovanen PT
J Lipid Res; 2012 Oct; 53(10):2115-2125. PubMed ID: 22855736
[TBL] [Abstract][Full Text] [Related]
19. Enhanced vascular permeability facilitates entry of plasma HDL and promotes macrophage-reverse cholesterol transport from skin in mice.
Kareinen I; Cedó L; Silvennoinen R; Laurila PP; Jauhiainen M; Julve J; Blanco-Vaca F; Escola-Gil JC; Kovanen PT; Lee-Rueckert M
J Lipid Res; 2015 Feb; 56(2):241-53. PubMed ID: 25473102
[TBL] [Abstract][Full Text] [Related]
20. Quantification of In Vitro Macrophage Cholesterol Efflux and In Vivo Macrophage-Specific Reverse Cholesterol Transport.
Escolà-Gil JC; Lee-Rueckert M; Santos D; Cedó L; Blanco-Vaca F; Julve J
Methods Mol Biol; 2015; 1339():211-33. PubMed ID: 26445792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
